Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.

SummaryOne-hundred and five patients with hypertension received nitrendipine (10–40 mg/day) or hydralazine (50–200 mg/day) in a double-blind randomized design. Nitrendipine decreased supine blood pressure 15/10 mm Hg, and hydralazine decreased it 11/11 mm Hg. Standing blood pressure was decreased 15